Stay updated on Sintilimab Plus Chidamide in ENKTCL Clinical Trial
Sign up to get notified when there's something new on the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page.

Latest updates to the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page
- Check6 days agoChange DetectedLocations section updated to include Guangdong and Hubei locations; revision noted as v3.3.3.SummaryDifference0.4%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.3.2 is now shown, replacing the previous Revision: v3.2.0.SummaryDifference0.1%

- Check41 days agoChange DetectedThe government funding/operating status notice was removed from the page, an administrative update that does not affect the trial’s core content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check56 days agoChange DetectedNo significant changes to the study details, eligibility criteria, enrollment, or outcomes were detected; the content and purpose of the page remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check84 days agoChange DetectedAdded a government-operating-status notice and a version bump to v3.2.0; removed the previous version label v3.1.0.SummaryDifference3%

- Check91 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Sintilimab Plus Chidamide in ENKTCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page.